Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity - PubMed (original) (raw)
Comparative Study
. 2004 Jan 1;13(1):69-78.
doi: 10.1093/hmg/ddh011. Epub 2003 Nov 12.
Affiliations
- PMID: 14613973
- DOI: 10.1093/hmg/ddh011
Comparative Study
Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity
Omar A Ibrahimi et al. Hum Mol Genet. 2004.
Abstract
Identical proline-->arginine gain-of-function mutations in fibroblast growth factor receptor (FGFR) 1 (Pro252Arg), FGFR2 (Pro253Arg) and FGFR3 (Pro250Arg), result in type I Pfeiffer, Apert and Muenke craniosynostosis syndromes, respectively. Here, we characterize the effects of proline-->arginine mutations in FGFR1c and FGFR3c on ligand binding using surface plasmon resonance and X-ray crystallography. Both Pro252Arg FGFR1c and Pro250Arg FGFR3c exhibit an enhancement in ligand binding in comparison to their respective wild-type receptors. Interestingly, binding of both mutant receptors to FGF9 was notably enhanced and implicates FGF9 as a potential pathophysiological ligand for mutant FGFRs in mediating craniosynostosis. The crystal structure, of Pro252Arg FGFR1c in complex with FGF2, demonstrates that the enhanced ligand binding is due to an additional set of receptor-ligand hydrogen bonds, similar to those gain-of-function interactions that occur in the Apert syndrome Pro253Arg FGFR2c-FGF2 crystal structure. However, unlike the Apert syndrome Pro253Arg FGFR2c mutant, neither the Pfeiffer syndrome Pro250Arg FGFR1c mutant nor the Muenke syndrome Pro250Arg FGFR3c mutant bound appreciably to FGF7 or FGF10. This observation provides a potential explanation for why the limb phenotypes, observed in type I Pfeiffer and Muenke syndromes, are less severe than the limb abnormalities observed in Apert syndrome. Hence, although analogous proline-->arginine mutations in FGFR1-3 act through a common structural mechanism to result in gain-of-function, differences in the primary sequence among FGFRs result in varying effects on ligand binding specificity.
Similar articles
- Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.
Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M. Bellus GA, et al. Nat Genet. 1996 Oct;14(2):174-6. doi: 10.1038/ng1096-174. Nat Genet. 1996. PMID: 8841188 - Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities.
Ibrahimi OA, Zhang F, Eliseenkova AV, Itoh N, Linhardt RJ, Mohammadi M. Ibrahimi OA, et al. Hum Mol Genet. 2004 Oct 1;13(19):2313-24. doi: 10.1093/hmg/ddh235. Epub 2004 Jul 28. Hum Mol Genet. 2004. PMID: 15282208 Free PMC article. - Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand.
Anderson J, Burns HD, Enriquez-Harris P, Wilkie AO, Heath JK. Anderson J, et al. Hum Mol Genet. 1998 Sep;7(9):1475-83. doi: 10.1093/hmg/7.9.1475. Hum Mol Genet. 1998. PMID: 9700203 - [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].
van Ravenswaaij-Arts CM, van den Ouweland AM, Hoogeboom AJ, Herbergs J, Pals G. van Ravenswaaij-Arts CM, et al. Ned Tijdschr Geneeskd. 2002 Jan 12;146(2):63-6. Ned Tijdschr Geneeskd. 2002. PMID: 11820058 Review. Dutch. - Syndromic craniosynostosis: from history to hydrogen bonds.
Cunningham ML, Seto ML, Ratisoontorn C, Heike CL, Hing AV. Cunningham ML, et al. Orthod Craniofac Res. 2007 May;10(2):67-81. doi: 10.1111/j.1601-6343.2007.00389.x. Orthod Craniofac Res. 2007. PMID: 17552943 Review.
Cited by
- Scaling up production of recombinant human basic fibroblast growth factor in an Escherichia coli BL21(DE3) plysS strain and evaluation of its pro-wound healing efficacy.
Li L, Yu B, Lai Y, Shen S, Yan Y, Dong G, Gao X, Cao Y, Ge C, Zhu L, Liu H, Tao S, Yao Z, Li S, Wang X, Hui Q. Li L, et al. Front Pharmacol. 2024 Feb 5;14:1279516. doi: 10.3389/fphar.2023.1279516. eCollection 2023. Front Pharmacol. 2024. PMID: 38375209 Free PMC article. - FGF signaling in cranial suture development and related diseases.
Zhao X, Erhardt S, Sung K, Wang J. Zhao X, et al. Front Cell Dev Biol. 2023 Jun 1;11:1112890. doi: 10.3389/fcell.2023.1112890. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37325554 Free PMC article. Review. - Mendelian inheritance revisited: dominance and recessiveness in medical genetics.
Zschocke J, Byers PH, Wilkie AOM. Zschocke J, et al. Nat Rev Genet. 2023 Jul;24(7):442-463. doi: 10.1038/s41576-023-00574-0. Epub 2023 Feb 20. Nat Rev Genet. 2023. PMID: 36806206 Review. - Quantitative Craniofacial Analysis and Generation of Human Induced Pluripotent Stem Cells for Muenke Syndrome: A Case Report.
Kidwai FK, Mui BWH, Almpani K, Jani P, Keyvanfar C, Iqbal K, Paravastu SS, Arora D, Orzechowski P, Merling RK, Mallon B, Myneni VD, Ahmad M, Kruszka P, Muenke M, Woodcock J, Gilman JW, Robey PG, Lee JS. Kidwai FK, et al. J Dev Biol. 2021 Sep 22;9(4):39. doi: 10.3390/jdb9040039. J Dev Biol. 2021. PMID: 34698187 Free PMC article. - A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain.
Light TP, Gomez-Soler M, Wang Z, Karl K, Zapata-Mercado E, Gehring MP, Lechtenberg BC, Pogorelov TV, Hristova K, Pasquale EB. Light TP, et al. J Biol Chem. 2021 Jul;297(1):100876. doi: 10.1016/j.jbc.2021.100876. Epub 2021 Jun 15. J Biol Chem. 2021. PMID: 34139238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous